Achievement
系统医学与健康以整体中医观点和系统生物学方法为基础来解决健康问题。该研究所开展的研究将涉及和整合来自分子、细胞的数据，以及对相互作用节点的结构和动力学的研究，形成多维矩阵的多个层面的网络，包括分子、细胞、器官、人、家庭、社区、社会和环境。我们提出了一种整体方法，鼓励研究人员、医疗保健教育工作者、中医从业者、临床医生和医疗保健领导者考虑以更加系统化的方式看待个人（作为一个受环境影响的复杂生物系统）。汇总后，此类个人信息可以更好地解释人口多样性（和人口医学），从而有助于为所有人实现更准确的诊断和有效的治疗结果。
May 2022: Director of SMHS, Professor LYU Aiping was elected as a foreign member of The Academy of Europe in the field of System Medicine.
November 2022: The team lead by Director of SMHS, Professor LYU Aiping and PIs, Professor ZHANG Ge, Dr. YU yuanyuan developed a novel aptamer, which has been approved by the U.S. FDA for rare disease drug designation (RPD-2022-667) and orphan drug designation (DRU-2022-9087).
April 2023: PI of SMHS, Dr. Yu Yuanyuan wins Silver Medal at Geneva International Exhibition of Inventions.
May 2023: Collaborator of SMHS, Dr. LYU Haitao, was elected Vice Chairman of Specialty Committee on Drug Metabolism.
May 2023: PI of SMHS, Professor JIA Wei, has been rewarded the President’s Award for Outstanding Performance in Scholarly Work.
May 2023: PI of SMHS, Dr. ZHANG Lu, has been rewarded the President’s Award for Outstanding Performance in Scholarly Work.
June 2023: PI of SMHS, Professor JIA Wei, have been elected as a member of the Academia Europaea.